Benno Therapeutics Welcomes SwiftPharma to the Leuven Lab Hotel to Co-Develop Plant-Based Oncology Breakthroughs
Benno Therapeutics is proud to announce it is opening its doors to longtime partner SwiftPharma in a move designed to radicalize collaborative research. SwiftPharma has officially established a dedicated R&D site within Benno’s existing infrastructure at the Leuven Lab Hotel, creating a unified powerhouse for plant-based drug development.
While SwiftPharma continues to maintain its corporate headquarters in Genk, this strategic co-location brings their specialized R&D team directly into Benno’s labs. By sharing both high-tech lab infrastructure and office spaces, the two companies aim to eliminate the friction of traditional distance-based partnerships. The joint mission is clear: accelerating the development of a groundbreaking cancer cure produced through plant-based molecular farming.
"Innovation is as much about environment as it is about science," says Erwin Blomsma, CEO of Benno Therapeutics. "Welcoming SwiftPharma into our facilities at the Leuven Lab Hotel creates a unique synergy. We aren't just collaborating on paper; we are sharing the same lab benches and the same daily drive to bring a plant-based cancer cure to patients. This is how you bridge the gap between discovery and impact."
"At SwiftPharma, we believe that the next generation of therapeutics requires a new way of working," adds Jeroen Hofenk, Founder and CSO of SwiftPharma. "Establishing this R&D site in Leuven while keeping our headquarters in Genk gives us the agility to work shoulder-to-shoulder with the Benno team. Sharing this infrastructure allows us to move at the speed of thought."
About Benno Therapeutics
Benno Therapeutics specializes in innovative therapies for oncological conditions in animals and strives to improve animal health through advanced biotechnology. The company is based in Heverlee.
About SwiftPharma
SwiftPharma is a Belgium-based privately held biotechnology company dedicated to developing next generation, animal-free, and affordable recombinant proteins by transforming plants into mini bioreactors. For more information, visit www.swiftpharma.eu